ENT Devices Market - By Product, By End-use & Forecast, 2023

Description

Global ENT devices market is slated to record substantial gains through 2032, pushed by the growing technological innovations in ENT devices. Moreover, players in the field have been focusing on devising hearing aids with integration capabilities to help users track their cognitive hearing. Citing an instance, in November 2022, Cochlear, a medical device company, received U.S. FDA clearance for its Nucleus® 8 Sound Processor, the smallest behind-the-ear cochlear implant sound processor, offering direct connectivity to daily consumer electronics via Bluetooth.

Overall, the ENT devices industry is segmented in terms of product, end-use, and region.

On the basis of product, the ENT devices market from the surgical ENT devices segment is poised to register noteworthy gains through 2032, owing to the growing occurrence of ENT disorders such as oral cancer, temporal bone cancer, and others that require surgeries for treatment. As per the American Cancer Society, in 2023, around 54,540 new cases of oropharyngeal cancer are estimated to be diagnosed in the U.S. alone. Furthermore, recent advancements in surgical equipment, such as image-guided surgery systems, have increased their applications in otorhinolaryngology, presenting lucrative opportunities for segment growth.

In terms of end-use, the ENT devices industry from the ENT clinics segment is anticipated to record a valuation of over USD 7 billion by 2032 on account of rising demand for advanced surgical and diagnostic procedures. These facilities also have strong availability of advanced diagnostic devices and skilled healthcare professionals resulting in increased patient footfall. Moreover, governments across the globe are investing ample amounts in ENT clinics, which is further set to augment segment growth.

From the regional perspective, the Europe ENT devices market garnered over USD 6 billion in 2022. The growing prevalence of ENT disorders has accentuated the need for ENT devices in the region. As per WHO, more than 190 million people in the WHO European Region have some degree of hearing loss.

Moreover, the robust presence of major industry leaders such as Sonova Holding AG, Lumenis Be Ltd, and others constantly indulging in innovating new products is also fueling regional expansion. For instance, in January 2023, Sonova Holding AG, a Swiss hearing care solutions provider, announced the launch of Sennheiser Conversation Clear Plus earbuds, new speech-enhanced hearable solutions to help users improve their comprehension in loud environments. This launch helped the company establish a new category of early-entry hearing solutions.

Product Code: 496

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 ENT devices industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product type trends
- 2.1.3 End-use trends
- 2.1.4 Regional trends

Chapter 3 ENT Devices Industry Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of ENT disorders globally
  - 3.2.1.2 Increasing geriatric population globally
  - 3.2.1.3 Technological advancements in the ENT devices
  - 3.2.1.4 Rising demand for minimally invasive ENT procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High procedure and instruments cost
  - 3.2.2.2 Social stigma across the globe
3.3 Growth potential analysis
- 3.3.1 By product type
- 3.3.2 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Technology landscape
3.7 Reimbursement scenario
- 3.7.1 U.S.
- 3.7.2 Europe
3.8 Future market trends
3.9 Gap analysis
3.10 Value-chain analysis
3.11 Porter's analysis
3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Strategy dashboard, 2022

Chapter 5 ENT Devices Market, By Product Type

5.1 Key product type trends
5.2 Diagnostic ENT Devices
- 5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.2.2 Rigid Endoscopes
  - 5.2.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  - 5.2.2.2 Rhinoscopes
    - 5.2.2.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  - 5.2.2.3 Laryngoscopes
    - 5.2.2.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  - 5.2.2.4 Otological Endoscopes
    - 5.2.2.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.2.3 Flexible Endoscopes
  - 5.2.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.2.4 Robot Assisted Endoscopes
  - 5.2.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.2.5 Hearing Screening Device
  - 5.2.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
5.3 Surgical ENT Devices
- 5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.3.2 Radiofrequency Handpieces
  - 5.3.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.3.3 Powered Surgical Instrument
  - 5.3.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.3.4 Otological Drill Burrs
  - 5.3.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.3.5 ENT Hand Instruments
  - 5.3.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.3.6 Tympanostomy Tubes
  - 5.3.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.3.7 Sinus Dilation Devices
  - 5.3.7.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.3.8 Nasal Packing Devices
  - 5.3.8.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
5.4 Hearing Aids
- 5.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.4.2 Behind-the-ear (BTE)
  - 5.4.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.4.3 Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
  - 5.4.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.4.4 In-the-canal (ITC)
  - 5.4.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.4.5 In-the-ear (ITE)
  - 5.4.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.4.6 Receiver in the ear/Receiver in Canal (RITE/RIC)
  - 5.4.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
5.5 Hearing Implants
- 5.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.5.2 Auditory Brainstem Implants
  - 5.5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.5.3 Cochlear Implants
  - 5.5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.5.4 Middle Ear Iimplants
  - 5.5.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.5.5 Bone Anchored Hearing System
  - 5.5.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
5.6 Voice Prosthesis Devices
- 5.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
5.7 Nasal Splints
- 5.7.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.7.2 Internal Nasal Splints
  - 5.7.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
- 5.7.3 External Nasal Splints
  - 5.7.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 6 ENT Devices Market, By End-use

6.1 Key end-use trends
6.2 Hospitals
- 6.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
6.3 Ambulatory surgical centers (ASCs)
- 6.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
6.4 ENT Clinics
- 6.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
6.5 Homecare
- 6.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 7 ENT Devices Market, By Region

7.1 Key regional trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Poland
- 7.3.7 Sweden
- 7.3.8 The Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Indonesia
- 7.4.7 Philippines
- 7.4.8 Vietnam
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Columbia
- 7.5.5 Chile
- 7.5.6 Peru
7.6 MEA
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Israel
- 7.6.5 Turkey
- 7.6.6 Egypt

Chapter 8 Company Profiles

8.1 DeSoutter Medical
8.2 Johnson & Johnson
8.3 Medtronic plc
8.4 Stryker Corporation
8.5 Zimmer Biomet
8.6 Olympus Corporation
8.7 WestCMR
8.8 Smith & Nephew plc
8.9 Nouvag AG
8.10 Vega Medical
8.11 Atos Medical
8.12 Boston Scientific Corporation
8.13 Cochlear
8.14 Lumenis Be Ltd
8.15 Meril Life Sciences Pvt. Ltd
8.16 Narang Medical Limited.
8.17 Sonova Group
8.18 Welch Allyn

ENT Devices Market - By Product, By End-use & Forecast, 2023 - 2032